Pathogenic mutations in Parkinson disease

by Tan E.-K., Skipper L.M.
Published 2018

Polymorphisms in candidate genes: Implications for the current treatment of Parkinson's disease

by Skipper L., Liu J.-J., Tan E.-K.
Published 2018

LRRK2 G2019S founder haplotype in the Chinese population

by Tan E.-K., Skipper L., Tan L., Liu J.-J.
Published 2018

Analysis of 14 LRRK2 mutations in Parkinson's plus syndromes and late-onset Parkinson's disease

by Tan E.-K., Skipper L., Chua E., Wong M.-C., Pavanni R., Bonnard C., Kolatkar P., Liu J.-J.
Published 2018

Comprehensive evaluation of common genetic variation within LRRK2 reveals evidence for association with sporadic Parkinson's disease

by Skipper L., Li Y., Bonnard C., Pavanni R., Yih Y., Chua E., Sung W.-K., Tan L., Wong M.-C., Tan E.-K., Liu J.
Published 2018

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients

by Tan E.K., Shen H., Tan L.C.S., Farrer M., Yew K., Chua E., Jamora R.D., Puvan K., Puong K.Y., Zhao Y., Pavanni R., Wong M.C., Yih Y., Skipper L., Liu J.-J.
Published 2018

Analysis of LRRK2 functional domains in nondominant Parkinson disease

by Skipper L., Shen H., Chua E., Bonnard C., Kolatkar P., Tan L.C.S., Jamora R.D., Puvan K., Puong K.Y., Zhao Y., Pavanni R., Wong M.C., Yuen Y., Farrer M., Liu J.J., Tan E.K.
Published 2018

The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: Genetic and functional evidence

by Tan E.K., Zhao Y., Skipper L., Tan M.G., Di Fonzo A., Sun L., Fook-Chong S., Tang S., Chua E., Yuen Y., Tan L., Pavanni R., Wong M.C., Kolatkar P., Lu C.S., Bonifati V., Liu J.J.
Published 2018